Quick search
Join
Home
>
Quiz
>
Biology & Life Sciences Chapter 32 Nucleotide Metabolism Matching Questions Use The
Sidebar
Close
Biology & Life Sciences Chapter 32 Nucleotide Metabolism Matching Questions Use The
0
Helpful
0
Unhelpful
May 8, 2023
Related documents
Econ 120 Practice Test Answers
Chapter 1 Business And Its Environment
Sociology
Wow My Love
Case Report Laquinta
Article Review: Administrators and Accountability: The Plurality of Value Systems in the Public Domain
FC 42957
FC 62472
FIN 91396
FE 34842
Unlock access to all the studying documents.
View Full Document
Chapter
32
Nucleotide Metab
olism
Matching Questions
Use the following
to answer que
stions 1
–
10:
Choose the cor
rect answer from
the list below. Not a
ll of the an
swers will be used.
a) de novo
b) xanthylate
c) riboflavin
d) amino acids
e) UTP
f)
N
5
,
N
10
-methyl
enetetrahydrofo
late
g) nucleotide
h) gout
i) nucleoside
j) ATP
k) urate
l) salvage
1.
Purines and pyri
midines are der
ived from __________
_______.
2.
Assembly of a co
mpound from s
impler molecules
is known as a(n) ____________
___ pathway.
Ans:
Section: 32.1
3.
Assembly of a co
mpound from phophor
ibosylpyrophos
phate
(
PRPP) and a base i
s known as
a(n) ____________
_____ pathway.
Ans:
Section: 32.1
4.
A purine or pyrim
idine base linked
to a sugar is a(n) __________
_______.
Ans:
Section: 32.1
5.
A purine or pyrim
idine base linked
to a sugar and to a
phosphate ester is
a(n)
_________________.
Section: 32.1
6.
CTP is formed by th
e amination of ____________
_____.
Ans:
Section: 32.2
7.
The intermediate
between inosin
ate and guanyla
te is _________________.
Ans:
b
Section: 32.3
Ans:
d
Section: Introduc
tion
Chapter 32 Nucl
eotide Metabolis
m
2
8.
The methyl donor
to make TMP is
_______________
__.
9.
High levels of ur
ate cause the di
sease _________________.
Ans:
h
Section: 32.6
10.
The final produc
t of purine degradation
is _________________.
Ans:
k
Section: 32.6
Fill
–
in
-the-Blank Que
stions
11.
DNA is built from _____.
Ans: deoxyribonucl
eotides
Section: 32.1
12.
Scaffolds for
the ring systems in nucleot
ides are from
the amino acids glyci
ne and _____.
Ans: aspartate
Sections: 32.2, 32.3
13.
In _____ biosyn
thesis the base
is assembled firs
t and then attached
to ribose.
Ans: pyrimidine
Section: 32.2
14.
Hypoxanthine-guani
ne phosphoribosyltransf
erase catalyzes
the formation of guan
ylate and
_____.
Ans: inosinate
Section: 32.3
15.
Fluorouracil acts
as an analog of _____.
Ans: dUMP
Section: 32.4
16.
Dihydrofolate r
eductase is an exc
ellent target for
anticancer drugs because it
is critical in the
synthesis of _____.
Ans: thymidylate
Section: 32.4
17.
The conversion of
ribonucleot
ides to deoxyribonuc
leotides is cat
alyzed by _____.
Ans: ribonucleotide
reductase
Section: 32.4
18.
The committed st
ep in purine nucleotid
e biosynthesis is the
conversion of _____ to 5-
phosphoribosyl-1-
amine.
Ans: PRPP
Section: 32.3
19.
_____ disease is c
aused by a genetic m
utation resulting
in the absence o
f hypoxanthine-guanine
phosphoribosylt
ransferase.
Ans: Lesch-
Ny
han
Section: 32.6
20.
Some individua
ls with a deficiency i
n the enzyme ad
enosine deaminase ex
hibit _____.
Ans: severe comb
ined immunodeficiency (SCI
D)
Section: 32.6
Ans:
Section: 32.4
Chapter 32 Nucl
eotide Metabolis
m
3
Multiple-Choice Ques
tions
21.
The source(s) of NH
2
g
roups in the synthes
is of nucleotides
is
(are)
A)
aspartate.
B)
glutamine.
C)
glycine.
D)
A and B.
E)
A, B, and C.
22.
Both de novo and sa
lvage paths are use
d in the synthesis o
f
A)
ribonucleotides.
B)
deoxyribonucleotide
s.
C)
dideoxyribonucleot
ides.
D)
All of the above.
E)
None of the above
.
Ans: A
Section: 32.2, 32.3
23.
TMP is made fro
m
A)
dTMP.
B)
dUMP.
C)
CTP.
D)
ATP.
E)
None of the above
.
Ans: B
Section: Figure 32.4
24.
In de novo synthes
is, the pyrimidine ring
is assembled using
A)
bicarbonate.
B)
aspartate.
C)
glutamine.
D)
A and B.
E)
A, B, and C.
Ans: E
Section: 32.3
25.
How many ATP
molecules are n
ecessary to make
carbamoyl pho
sphate by carba
moyl phosphate
synthetase (CPS)?
A)
1
B)
4
C)
2
D)
3
E)
None of the above
.
Ans: C
Section: 32.1
26.
Wh
ich enzyme ca
rries out th
is
reaction
:
XDP + YTP
↔
XTP + YD
P?
A)
nucleoside triphos
phate kinase
B)
nucleoside dipho
sphate kinase
C)
nucleoside dipho
sphate phosphory
lase
D)
nucleoside triphos
phate phosphorylase
E)
None of the above
.
Ans: B
Section: 32.2
An
s:
D
Section: 32.2
Chapter 32 Nucl
eotide Metabolis
m
4
27.
The synthesis of CTP
from UTP
requires UTP and
A)
glutamine and ATP.
B)
glycine and ATP.
C)
glutamine, ATP, and NA
DH.
D)
All of the above.
E)
None of the above
.
28.
Which enzyme(s) c
atalyze(s) the first st
ep in de novo nucleot
ide biosynthesis?
A)
aspartate transcarb
amylase
B)
nucleoside monop
hosphate kinase
C)
glutamine phosphor
ibosyl amid
otransferase
D)
A and B.
E)
A and C.
Ans: C
Section: 32.3
29.
The displacing nuc
leophile in pyrimid
ine synthesis is t
ypically
A)
ammonia or an
amino group.
B)
a metal ion.
C)
coenzyme A.
D)
All of the above.
E)
None of the above
.
Ans: A
Section: 32.2
30.
Inosinate can be
converted
to
A)
AMP.
B)
GMP.
C)
UMP.
D)
A or B.
E)
A, B, or C.
Ans: D
Section: 32.3
31.
The ultimate redu
ctant in synthesis of d
eoxyribonucle
otides
is
A)
FADH
2
.
B)
NADH
.
C)
NADPH.
D)
quinone.
E)
None of the above.
Ans: C
Section: 32.4
32.
Which amino ac
id side chain in
thymidylate synthase
activates the
ring of dUMP, making C-5
a
good nucleophile?
A)
cysteine
B)
aspartate
C)
glutamine
D)
tyrosine
E)
serine
Ans: A
Section: 32.4
Ans: A
Section: 32.2
Chapter 32 Nucl
eotide Metabolis
m
5
33.
Tetrahydrofola
te is generated from
dihydrofolate by dihydro
folate reductase and u
ses the
reductant
A)
FADH
2
.
B)
NADH.
C)
NADPH.
D)
riboflavin.
E)
None of the above
.
34.
The competitive i
nhibitor(s) of d
ihydrofolate reduct
ase
is
(are
)
A)
aminopterin.
B)
methotrexate.
C)
fluorouracil.
D)
A and B.
E)
B and C.
Ans: D
Section: 32.4
35.
Allopurinol is u
sed to treat gout and i
s an inhibito
r of the enzyme(s)
A)
xanthine oxidase.
B)
xanthine hydrola
se.
C)
hypoxanthine-guanine
phosphoribosyltran
sferase.
D)
All of the above.
E)
None of the above
.
Ans: A
Section: 32.6
36.
Sulfa drugs are a
nalogs of
p
-aminobenz
oate, a compo
und necessary for
N
10
–
formyltetrahyd
rofolate. How do these d
rugs act on bac
terial infections and why
are humans not
susceptible?
A)
N
10
-formyltetrahyd
rofolate
is
a ferredoxi
n analog and a poten
t inhibitor of
ribonucleotide
reductase in ba
cteria but not hu
mans.
B)
N
10
-formyltetrahyd
rofolate is a ferredoxin ana
log and a potent
inhibitor of ribonuc
leotide
reductase, but hu
mans consume suffi
cient quantities of fer
redoxin in their d
iet to saturate
the reductase.
C)
N
10
-formyltetrahyd
rofolate is an NADPH an
alog and a poten
t inhibitor of ribon
ucleotide
reductase in ba
cteria but not hu
mans.
D)
N
10
-formyltetrahyd
rofolate twice transfers a fo
rmyl group dur
ing de novo synthes
is of the
purine ring. Bact
eria dihydrofolate
reductase is blo
cked by sulfa drug
s, whereas the
human enzyme is
not.
E)
N
10
-formyltetrahyd
rofolate twice transfers a
formyl gro
up during de novo syn
thesis of the
purine ring. Bacter
ia synthesize th
eir own folate, wh
ereas humans get th
eirs from eating
green plants.
Ans:
E
Section: 32.3
Ans: C
Section: 32.4
Chapter 32 Nucl
eotide Metabolis
m
6
37.
What intermedi
ate in pyrimidine syn
thesis will accu
mulate if a strain of
bacteria is lack
ing in
aspartate?
A)
orotidylate
B)
orotate
C)
dihydroorotate
D)
5-phosphoribosyl-1-am
ine
E)
carbamoyl phosph
ate
38.
Pyrimidine biosyn
thesis is allowed to t
ake place in th
e presence of
[
15
N
]aspartate. What
position
would be labeled i
n the newly synthe
sized nucleotides?
A)
N
3
in IMP
B)
N
7
in IMP
C)
N
9
in Imp
D)
N
1
in UTP
E)
N
3
in UTP
Ans:
D
Section: 32.1
39.
Human beings co
ntain two differ
ent carbamoyl pho
sphate synthetase
enzymes. If
you wanted to
study the enzyme
inhibition for
the enzyme specific
for nucleotide synthesis, wh
ich of the
following analog
s would you choo
se?
A)
analog for bica
rbonate
B)
analog for carbox
yphosphate
C)
analog for carbam
ic acid
D)
analog for NH
3
E)
analog for glutam
ine
Ans:
E
Section: 32.2
40.
How is the purin
e nucleotide cycle
linked to the citri
c acid cycle?
A)
The purine nucleo
tide cycle serves a
s an anapleurotic
reaction for th
e formation of
oxaloacetate.
B)
The purine nucleo
tide cycle serves a
s an anapleurotic
reaction for th
e formation of
fumarate.
C)
The purine nucleo
tide cycle serves a
s an anapleurotic
reaction for th
e formation of
pyruvate.
D)
The condensation o
f IMP with glu
tamate generate
s adenylosucc
inate, which is
hydrolyzed to fo
rm succinate.
E)
The condensation o
f IMP with glu
tamine generate
s adenylosuccinate, wh
ich is
hydrolyzed to fo
rm succinate.
Ans:
B
Section: 32.3
Short-Answer Questi
ons
Ans:
E
Section: 32.2
Chapter 32 Nucl
eotide Metabolis
m
7
41.
Why is nucleot
ide synthesis an imp
ortant pathway
for medical interve
ntion? What type
s of
disease could be
treated using this
information?
42.
Given the functio
n of nucleotides, wou
ld you expect
their synthesis to b
e simple or compl
ex and
diverse?
reactions were uti
lized and small me
tabolic pathway di
fferences deve
loped that
accompanied th
e need to make d
ifferent nucleotid
es.
Section: 32.1
43.
Describe the react
ion by which carba
moyl phosphate s
ynthetase acquires an a
mmonia to
make
carbamoyl phosph
ate.
Ans:
A component of
the enzyme hydroly
zes glutamine, fo
rming glutama
te and ammonia.
Section: 32.2
44.
What is the adv
antage of channeling
intermediates by c
arbamoyl phosphate
synthetase?
then channeled to
the site of ca
rbamoyl phospha
te synthesis. The subs
trates are protec
ted
from hydrolys
is, and not lost by di
ffusion.
Section: 32.2
45.
What reaction ac
tually forms the six-member
ring found in p
yrimidines?
nitrogen poised nea
r a carboxylic acid
group. These groups r
eact and cyclization resul
ts
in dihydroorotate
formation.
Section: 32.2
46.
How is pyrimidine
biosynthesis r
egulated?
transcarbamoyla
se (ATCase). ATC
ase is activat
ed by ATP and is inhibited by
the final
product of de novo py
rimidine synth
esis, CTP.
Section: 32.5
47.
Why do purine sal
vage pathways save
the cell energy?
Ans:
Free purines can b
e attached to PRPP
in a single-step react
ion to form nucl
eoside
monophosphates.
Section: 32.3
48.
What is a general
theme in purine r
ing synthesis, in
terms of reaction lo
gic and mechanism?
carbon-bound oxygen a
tom, followed
by loss of the phosphoryl g
roup, via a disp
lacement
reaction in which a nu
cleophile ac
ts as the displacing
agent.
Section: 32.3
in cancer therapy.
Sections: 32.5 and 32.6
Chapter 32 Nucl
eotide Metabolis
m
8
49.
How is the recipro
cal use of nuc
leotides useful
in purine synthesis
?
50.
What is the disadv
antage of me
thotrexate as a ther
apeutic agent?
loss of immune syste
m protection, n
ausea, and hair loss.
Section: 32.6
51.
How is ATCase, a ke
y enzyme
in pyrimidine biosyn
thesis, inhibite
d?
classic example o
f feedback inh
ibition.
Section: 32.5
52.
Wh
ich vitamin sup
plement is taken
during the firs
t trimester of pregnanc
y to prevent the bir
th
defect known as spi
na bifida?
precursors requ
ired during freq
uent cell divis
io
n and substant
ial DNA synthesis.
Section: 32.6
53.
What are advant
ages of high urate
levels?
Ans:
Urate is a highly ef
fective scavenger o
f reactive oxyge
n species (ROS).
Section: 32.6
an opportunity fo
r balance in the
regulatory proces
ses.
Section: 32.3